In fact, Bcl-xL has been found up-regulated in PMF cells [42,43], while a deregulation of TRAIL, DR4, and DR5 expression has been described in ET and PV cells [44], suggesting that alterations in the apoptotic pathways are intrinsic MPN features. Here, BCL2L1 is linked to myeloproliferative disorder.